Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversible congestive heart failure associated with diabetes mellitus in two cats.

JFMS open reports·2026
Same author

Spinal cord extracellular matrix hydrogel enhances organoid maturation and functional regeneration after spinal cord injury.

Materials today. Bio·2026
Same author

Targeted KEAP1 disruption enhances antioxidant defense and mesenchymal stromal cell therapy for chronic limb-threatening ischemia.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Slippery dopamine-fluoropolymer hybrid surface for improving biliary stent longevity.

Bioactive materials·2026
Same author

Microfluidics-guided localized low-temperature modulation of axonal signal propagation.

Lab on a chip·2026
Same author

Targeted Nanocomplex Delivery for Protecting Vascular Integrity and Enhancing Anticancer Effects in Hepatocellular Carcinoma.

Small science·2026

Related Experiment Video

Updated: Aug 19, 2025

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

2.7K

Engineered human cardiac tissues for modeling heart diseases.

Sungjin Min1, Seung-Woo Cho2

  • 1Department of Biotechnology, Yonsei University, Seoul 03722, Korea.

BMB Reports
|November 28, 2022
PubMed
Summary

Advanced 3D cardiac tissue models using human cells and bioengineering overcome limitations of traditional methods. These engineered heart tissues (EHTs) improve heart disease modeling and drug testing accuracy.

More Related Videos

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

10.4K
Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

6.6K

Related Experiment Videos

Last Updated: Aug 19, 2025

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

2.7K
Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

10.4K
Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

6.6K

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Tissue Engineering

Background:

  • Heart disease poses a significant global health threat with high mortality.
  • Conventional models (primary cells, animals) struggle with accuracy and reproducibility in disease modeling and drug evaluation.
  • Limitations necessitate advanced models for better understanding and treatment development.

Conclusions:

  • 3D cardiac tissue models represent a significant improvement for studying heart diseases.
  • The combination of cell reprogramming and bioengineering is key to developing mature and complex cardiac models.
  • These models offer a more accurate platform for disease pathophysiology and therapeutic evaluation.